Table 2 Univariable analyses of event-free survival (EFS) of AML patients from TCGA database
From: CEBPE expression is an independent prognostic factor for acute myeloid leukemia
Variable | HR | 95% CI | P-value |
|---|---|---|---|
CEBPE, high vs. low | 0.5 | 0.4–0.8 | 0.00098 |
Age, ≥ 60 vs. < 60 | 2.8 | 2.0–4.1 | 2.86E−08 |
log2(WBC), each 2-unit increase | 1.2 | 1.0–1.3 | 0.074 |
DNMT3A, mutation vs. wild-type | 1.5 | 1.0–2.2 | 0.039 |
RUNX1, mutation vs. wild-type | 1.6 | 1.0–2.7 | 0.093 |
TP53, mutation vs. wild-type | 3.2 | 1.9–5.6 | 2.76E−05 |
inv(16) vs. others | 0.3 | 0.1–0.9 | 0.039 |
t(15;17) vs. others | 0.3 | 0.1–0.8 | 0.015 |
t(9;11) vs. others | 3.9 | 0.9–16.0 | 0.061 |
t(11q23) vs. others | 2.5 | 1.1–5.7 | 0.033 |